Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

BIZARRE: Spero rapeutics | Mind Blowing Facts

Spero Therapeutics' Shares Plunge As FDA Issued Refusal Letter For Urinary Tract Infection Candidate

The U.S.

Benzinga · Jun 27, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022

Upgrades

Benzinga · May 20, 2022

Recap: Spero Therapeutics Q1 Earnings

Spero Therapeutics (NASDAQ:SPRO) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga · May 16, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022

Upgrades

Benzinga · May 4, 2022

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga · May 3, 2022

A Preview Of Spero Therapeutics's Earnings

Spero Therapeutics (NASDAQ:SPRO) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Spero Therapeutics will report an earnings per share (EPS) of $-0.75.

Benzinga · Mar 30, 2022

Coverage From

Benzinga

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.